Olfactory dysfunction in humans with deficient guanine nucleotide-binding protein

Ruth S. Weinstock, Herbert N. Wright, Allen M. Spiegel, Michael A. Levine, Arnold M. Moses

Research output: Contribution to journalArticle

44 Citations (Scopus)

Abstract

The guanine nucleotide-binding stimulatory protein (Gs) couples hormone-receptor interaction to the activation of adenylate cyclase and the generation of cyclic AMP (see ref. 1 for a review). Studies using frog neuroepithelium indicate that the sense of smell is mediated by a G s-adenylate cyclase system2, and this prompted us to test olfaction in the only known model of Gs deficiency in the animal kingdom, Gs-deficient (type 1a) pseudohypoparathyroidism (PHP), which occurs in humans3-8. Such patients are resistant to the cAMP-mediated actions of several hormones9. (Although Henkin 10 has reported disturbances in the sense of smell in six patients with PHP, currently available biochemical measurements such as the cAMP response to parathyroid hormone (PTH) and determination of Gs activity were not reported and olfactory testing was limited.) In the present study, we found that all Gs-deficient patients had impaired olfaction when compared with PHP patients who had normal Gs activity (type 1b PHP, in which patients are resistant only to the action of PTH in the kidney). This is the first evidence of human olfactory impairment which can be related to G s deficiency and suggests that Gs-deficient PHP patients may be resistant to cAMP-mediated actions in other non-endocrine systems.

Original languageEnglish (US)
Pages (from-to)635-636
Number of pages2
JournalNature
Volume322
Issue number6080
DOIs
StatePublished - 1986
Externally publishedYes

Fingerprint

Guanine Nucleotides
Pseudohypoparathyroidism
Carrier Proteins
Smell
Parathyroid Hormone
Adenylyl Cyclases
Anura
Cyclic AMP
Hormones
Kidney

ASJC Scopus subject areas

  • General

Cite this

Weinstock, R. S., Wright, H. N., Spiegel, A. M., Levine, M. A., & Moses, A. M. (1986). Olfactory dysfunction in humans with deficient guanine nucleotide-binding protein. Nature, 322(6080), 635-636. https://doi.org/10.1038/322635a0

Olfactory dysfunction in humans with deficient guanine nucleotide-binding protein. / Weinstock, Ruth S.; Wright, Herbert N.; Spiegel, Allen M.; Levine, Michael A.; Moses, Arnold M.

In: Nature, Vol. 322, No. 6080, 1986, p. 635-636.

Research output: Contribution to journalArticle

Weinstock, RS, Wright, HN, Spiegel, AM, Levine, MA & Moses, AM 1986, 'Olfactory dysfunction in humans with deficient guanine nucleotide-binding protein', Nature, vol. 322, no. 6080, pp. 635-636. https://doi.org/10.1038/322635a0
Weinstock, Ruth S. ; Wright, Herbert N. ; Spiegel, Allen M. ; Levine, Michael A. ; Moses, Arnold M. / Olfactory dysfunction in humans with deficient guanine nucleotide-binding protein. In: Nature. 1986 ; Vol. 322, No. 6080. pp. 635-636.
@article{6cfc0f539ed34d9fb32eb293440a9220,
title = "Olfactory dysfunction in humans with deficient guanine nucleotide-binding protein",
abstract = "The guanine nucleotide-binding stimulatory protein (Gs) couples hormone-receptor interaction to the activation of adenylate cyclase and the generation of cyclic AMP (see ref. 1 for a review). Studies using frog neuroepithelium indicate that the sense of smell is mediated by a G s-adenylate cyclase system2, and this prompted us to test olfaction in the only known model of Gs deficiency in the animal kingdom, Gs-deficient (type 1a) pseudohypoparathyroidism (PHP), which occurs in humans3-8. Such patients are resistant to the cAMP-mediated actions of several hormones9. (Although Henkin 10 has reported disturbances in the sense of smell in six patients with PHP, currently available biochemical measurements such as the cAMP response to parathyroid hormone (PTH) and determination of Gs activity were not reported and olfactory testing was limited.) In the present study, we found that all Gs-deficient patients had impaired olfaction when compared with PHP patients who had normal Gs activity (type 1b PHP, in which patients are resistant only to the action of PTH in the kidney). This is the first evidence of human olfactory impairment which can be related to G s deficiency and suggests that Gs-deficient PHP patients may be resistant to cAMP-mediated actions in other non-endocrine systems.",
author = "Weinstock, {Ruth S.} and Wright, {Herbert N.} and Spiegel, {Allen M.} and Levine, {Michael A.} and Moses, {Arnold M.}",
year = "1986",
doi = "10.1038/322635a0",
language = "English (US)",
volume = "322",
pages = "635--636",
journal = "Nature",
issn = "0028-0836",
publisher = "Nature Publishing Group",
number = "6080",

}

TY - JOUR

T1 - Olfactory dysfunction in humans with deficient guanine nucleotide-binding protein

AU - Weinstock, Ruth S.

AU - Wright, Herbert N.

AU - Spiegel, Allen M.

AU - Levine, Michael A.

AU - Moses, Arnold M.

PY - 1986

Y1 - 1986

N2 - The guanine nucleotide-binding stimulatory protein (Gs) couples hormone-receptor interaction to the activation of adenylate cyclase and the generation of cyclic AMP (see ref. 1 for a review). Studies using frog neuroepithelium indicate that the sense of smell is mediated by a G s-adenylate cyclase system2, and this prompted us to test olfaction in the only known model of Gs deficiency in the animal kingdom, Gs-deficient (type 1a) pseudohypoparathyroidism (PHP), which occurs in humans3-8. Such patients are resistant to the cAMP-mediated actions of several hormones9. (Although Henkin 10 has reported disturbances in the sense of smell in six patients with PHP, currently available biochemical measurements such as the cAMP response to parathyroid hormone (PTH) and determination of Gs activity were not reported and olfactory testing was limited.) In the present study, we found that all Gs-deficient patients had impaired olfaction when compared with PHP patients who had normal Gs activity (type 1b PHP, in which patients are resistant only to the action of PTH in the kidney). This is the first evidence of human olfactory impairment which can be related to G s deficiency and suggests that Gs-deficient PHP patients may be resistant to cAMP-mediated actions in other non-endocrine systems.

AB - The guanine nucleotide-binding stimulatory protein (Gs) couples hormone-receptor interaction to the activation of adenylate cyclase and the generation of cyclic AMP (see ref. 1 for a review). Studies using frog neuroepithelium indicate that the sense of smell is mediated by a G s-adenylate cyclase system2, and this prompted us to test olfaction in the only known model of Gs deficiency in the animal kingdom, Gs-deficient (type 1a) pseudohypoparathyroidism (PHP), which occurs in humans3-8. Such patients are resistant to the cAMP-mediated actions of several hormones9. (Although Henkin 10 has reported disturbances in the sense of smell in six patients with PHP, currently available biochemical measurements such as the cAMP response to parathyroid hormone (PTH) and determination of Gs activity were not reported and olfactory testing was limited.) In the present study, we found that all Gs-deficient patients had impaired olfaction when compared with PHP patients who had normal Gs activity (type 1b PHP, in which patients are resistant only to the action of PTH in the kidney). This is the first evidence of human olfactory impairment which can be related to G s deficiency and suggests that Gs-deficient PHP patients may be resistant to cAMP-mediated actions in other non-endocrine systems.

UR - http://www.scopus.com/inward/record.url?scp=0022521964&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0022521964&partnerID=8YFLogxK

U2 - 10.1038/322635a0

DO - 10.1038/322635a0

M3 - Article

C2 - 3018580

AN - SCOPUS:0022521964

VL - 322

SP - 635

EP - 636

JO - Nature

JF - Nature

SN - 0028-0836

IS - 6080

ER -